599 related articles for article (PubMed ID: 22823866)
21. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
[TBL] [Abstract][Full Text] [Related]
22. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
23. Effects of progesterone administration and APPswe+PSEN1Deltae9 mutation for cognitive performance of mid-aged mice.
Frye CA; Walf AA
Neurobiol Learn Mem; 2008 Jan; 89(1):17-26. PubMed ID: 17988898
[TBL] [Abstract][Full Text] [Related]
24. Decreased circadian fluctuation in cognitive behaviors and synaptic plasticity in APP/PS1 transgenic mice.
He Y; Li Y; Zhou F; Qi J; Wu M
Metab Brain Dis; 2020 Feb; 35(2):343-352. PubMed ID: 31879834
[TBL] [Abstract][Full Text] [Related]
25. A detailed analysis of the early context extinction deficits seen in APPswe/PS1dE9 female mice and their relevance to preclinical Alzheimer's disease.
Bonardi C; de Pulford F; Jennings D; Pardon MC
Behav Brain Res; 2011 Sep; 222(1):89-97. PubMed ID: 21440575
[TBL] [Abstract][Full Text] [Related]
26. Treadmill exercise prevents decline in spatial learning and memory in APP/PS1 transgenic mice through improvement of hippocampal long-term potentiation.
Liu HL; Zhao G; Cai K; Zhao HH; Shi LD
Behav Brain Res; 2011 Apr; 218(2):308-14. PubMed ID: 21192984
[TBL] [Abstract][Full Text] [Related]
27. Chronic ramelteon treatment in a mouse model of Alzheimer's disease.
McKenna JT; Christie MA; Jeffrey BA; McCoy JG; Lee E; Connolly NP; Ward CP; Strecker RE
Arch Ital Biol; 2012 Mar; 150(1):5-14. PubMed ID: 22786833
[TBL] [Abstract][Full Text] [Related]
28. Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1DeltaE9 mouse model of Alzheimer's disease.
Toledo EM; Inestrosa NC
Mol Psychiatry; 2010 Mar; 15(3):272-85, 228. PubMed ID: 19621015
[TBL] [Abstract][Full Text] [Related]
29. Decreased hippocampal cell proliferation correlates with increased expression of BMP4 in the APPswe/PS1DeltaE9 mouse model of Alzheimer's disease.
Li D; Tang J; Xu H; Fan X; Bai Y; Yang L
Hippocampus; 2008; 18(7):692-8. PubMed ID: 18398851
[TBL] [Abstract][Full Text] [Related]
30. Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model.
Pillay NS; Kellaway LA; Kotwal GJ
Behav Brain Res; 2008 Oct; 192(2):173-7. PubMed ID: 18490064
[TBL] [Abstract][Full Text] [Related]
31. Effects of ramelteon and triazolam in a mouse genetic model of early morning awakenings.
Wisor JP; Jiang P; Striz M; O'Hara BF
Brain Res; 2009 Nov; 1296():46-55. PubMed ID: 19664610
[TBL] [Abstract][Full Text] [Related]
32. Aspects of spatial memory and behavioral disinhibition in Tg2576 transgenic mice as a model of Alzheimer's disease.
Ognibene E; Middei S; Daniele S; Adriani W; Ghirardi O; Caprioli A; Laviola G
Behav Brain Res; 2005 Jan; 156(2):225-32. PubMed ID: 15582108
[TBL] [Abstract][Full Text] [Related]
33. Stimulatory effects of a melatonin receptor agonist, ramelteon, on BDNF in mouse cerebellar granule cells.
Imbesi M; Uz T; Dzitoyeva S; Manev H
Neurosci Lett; 2008 Jul; 439(1):34-6. PubMed ID: 18501512
[TBL] [Abstract][Full Text] [Related]
34. Early memory deficits precede plaque deposition in APPswe/PS1dE9 mice: involvement of oxidative stress and cholinergic dysfunction.
Zhang W; Bai M; Xi Y; Hao J; Liu L; Mao N; Su C; Miao J; Li Z
Free Radic Biol Med; 2012 Apr; 52(8):1443-52. PubMed ID: 22342520
[TBL] [Abstract][Full Text] [Related]
35. Melatonin receptor agonist ramelteon activates the extracellular signal-regulated kinase 1/2 in mouse cerebellar granule cells.
Imbesi M; Uz T; Manev H
Neuroscience; 2008 Sep; 155(4):1160-4. PubMed ID: 18664376
[TBL] [Abstract][Full Text] [Related]
36. The endogenous melatonin (MT) signal facilitates reentrainment of the circadian system to light-induced phase advances by acting upon MT2 receptors.
Pfeffer M; Rauch A; Korf HW; von Gall C
Chronobiol Int; 2012 May; 29(4):415-29. PubMed ID: 22489607
[TBL] [Abstract][Full Text] [Related]
37. Chronic phosphodiesterase type 2 inhibition improves memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Sierksma AS; Rutten K; Sydlik S; Rostamian S; Steinbusch HW; van den Hove DL; Prickaerts J
Neuropharmacology; 2013 Jan; 64():124-36. PubMed ID: 22771768
[TBL] [Abstract][Full Text] [Related]
38. A modified preparation (LMK03) of the oriental medicine Jangwonhwan reduces Abeta(1-42) level in the brain of Tg-APPswe/PS1dE9 mouse model of Alzheimer disease.
Seo JS; Jung EY; Kim JH; Lyu YS; Han PL; Kang HW
J Ethnopharmacol; 2010 Aug; 130(3):578-85. PubMed ID: 20669372
[TBL] [Abstract][Full Text] [Related]
39. Age-related changes in visual acuity, learning and memory in the APPswe/PS1dE9 mouse model of Alzheimer's disease.
Stover KR; Brown RE
Behav Brain Res; 2012 May; 231(1):75-85. PubMed ID: 22409975
[TBL] [Abstract][Full Text] [Related]
40. Effects of aging and genotype on circadian rhythms, sleep, and clock gene expression in APPxPS1 knock-in mice, a model for Alzheimer's disease.
Duncan MJ; Smith JT; Franklin KM; Beckett TL; Murphy MP; St Clair DK; Donohue KD; Striz M; O'Hara BF
Exp Neurol; 2012 Aug; 236(2):249-58. PubMed ID: 22634208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]